The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer—results from the RAPIDO trial
E.A. Dijkstra1, W.H. Zwart1, P.J. Nilsson2, H. Putter3, A.G.H. Roodvoets4, E. Meershoek-Klein Kranenbarg4, J.E. Frödin5, P. Nygren6, L. Østergaard7, C. Kersten8, I. Verbiené9, A. Cervantes10, M.P. Hendriks11, J. Capdevila12, I. Edhemovic13, C.J.H. van de Velde4, C.A.M. Marijnen14,15, B. van Etten16, G.A.P. Hospers1, B. Glimelius6
1Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
2Department of Surgery, Karolinska University Hospital, Stockholm, Sweden
3Departments of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands
4Departments of Surgery, Leiden University Medical Center, Leiden, The Netherlands
5Department of Oncology-Pathology, Karolinska University Hospital, Uppsala
6Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
7Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark
8Department of Research, Sørlandet Hospital Trust, Kristiansand, Norway
9Department of Oncology, Uppsala University, Uppsala, Sweden
10Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain
11Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands
12Department of Medical Oncology, Vall Hebron Institute of Oncology (VHIO), Vall Hebron University Hospital. Autonomous University of Barcelona (UAB), Barcelona, Spain
13Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
14Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam
15Department of Radiation Oncology, Leiden University Medical Center, Leiden
16Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands